Nanoform and Celanese Explore Ways to Enhance Drug Delivery
Nanoform
Press release
Nanoform and Celanese Explore Ways to Enhance Drug Delivery
Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Celanese Corporation (NYSE: CE), a global specialty materials company, today announced plans to explore the synergies between their respective technologies in the field of nanoparticle-enabled drug delivery.
The goal is to assess the utility of combining Nanoform’s nanoparticle platform technologies with Celanese’s VitalDose
® EVA copolymer delivery technology for drug-eluting implants. The aims are to enable the development of next-generation drug delivery devices that support increased drug load and possess enhanced sustained release properties. Nanoform and Celanese intend to work on formulation development, leveraging each organization’s unique formulation expertise.
Nasdaq Nordic: Nasdaq Copenhagen welcomes Donkey Republic A/S to Nasdaq First North Growth Market
Copenhagen May 25, 2021 - Nasdaq (Nasdaq: NDAQ) announces that trading in the
Donkey Republic share (short name: DONKEY) starts today on Nasdaq First North
Growth Market Denmark. Donkey Republic belongs to the Consumer Products &
Services technology sector and is the 10th company which will be admitted to
trading on Nasdaq Copenhagen in 2021 and is the 55th company on the Nasdaq
Nordic Market .
Donkey Republic is a leading provider of end-to-end bike-sharing solutions. The
Company is expanding across Europe and as of Q1 2021 it operates +10,100 bikes
in 15 cities as well as licenses its platform to partners operating +2,700
About Sinch
Sinch brings businesses and people closer with tools enabling personal engagement. Its leading cloud communications platform lets businesses reach every mobile phone on the planet, in seconds or less, through mobile messaging, voice and video. Sinch is a trusted software provider to mobile operators, and its platform powers business-critical communications for many of the world’s largest companies. Sinch has been profitable and fast-growing since its foundation in 2008. It is headquartered in Stockholm, Sweden, and has local presence in more than 40 countries. Shares are traded at NASDAQ Stockholm: XSTO:SINCH. Visit us at sinch.com.
This information is information that Sinch AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the above mentioned contact person, at 23:59 CEST on 24 May 2021.
Elicera Therapeutics’ first day to subscribe ahead of the listing at Nasdaq First North Growth Market
Elicera Therapeutics
Publicerad: 24 maj 2021, 08:30
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS SUBJECT IN WHOLE OR IN PART TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN ELICERA THERAPEUTICS AB. SEE ALSO THE IMPORTANT INFORMATION SECTION BELOW.
Gothenburg, Sweden May 24, 2021 - Elicera Therapeutics, a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T cells and oncolytic viruses, announces that the subscription period for the company s new share issue prior to the planned listing on Nasdaq First North Growth Market begins today and
Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH
Sinch AB (publ) (“Sinch” or the “Company”) has mandated Carnegie, Danske Bank, Handelsbanken Capital Markets, JP Morgan and SEB (together, the “Joint Bookrunners”) to evaluate the conditions for carrying out a directed new share issue of up to approximately 7.2 million shares, through an accelerated book building process. Temasek has, subject to the subscription price in the directed new share issue not exceeding a price per share corresponding to a discount of 4 percent in relation to the volume weighted average share price of the Company’s share on 24 May 2021, committed to be part of the directed new share issue by subscribing for shares equivalent to SEK 2,085 million at the bookbuilding price. SB Northstar LP, a fund managed by SB Management, a wholly owned direct subsidiary of SoftBank Group Corp, (“SB Management”), has also committed to be part of the directed new share issue by subscribing for up to app